GCPL shares trade lower: Firm expects double-digit revenue growth in Q3; here’s what analysts said

“Demand conditions in India strengthened progressively during the quarter. We remain confident of a gradual improvement in consumption over the coming quarters, supported by falling inflation and improving affordability following lower GST rates,” the company said in a regulatory filing.

Against this backdrop, GCPL further said its standalone business remains well positioned to post double-digit revenue growth for Q3 FY26, supported by near double-digit underlying volume growth, aided by a favourable base effect.

“This outperformance continues to be driven by the Home Care segment, where momentum remains robust and we expect to deliver double-digit value growth, supported by sustained consumer demand and effective in-market execution,” the company added. The firm’s personal care is expected to record mid-single-digit value growth, driven by a marked recovery in the soaps category.

GCPL expects standalone EBITDA margins to revert to the normative range, aided by favourable input costs, disciplined cost management, calibrated pricing actions, and improved operating leverage.

In the international category, GCPL said in Indonesia, competitive pricing pressures across key categories persisted during Q3 FY26. “We do see early signs of stabilisation and expect an improvement in both revenue and profitability from FY27 onwards,” the company said.

GAUM (Godrej Africa, USA, and Middle East) continued to deliver a strong and consistent performance both on the topline and bottom line, the company said, adding the cluster is well poised to deliver FY26 in accordance with its guidance of double-digit top- and bottom-line growth.

“At the consolidated level, we expect close to double-digit revenue growth in INR terms and double-digit EBITDA growth, reflecting the strength of our category development-led growth strategy and improving trends across our international businesses,” GCPL said.

Here’s what analysts said

For Q3 FY26F, they expect consolidated margins of 20.7%, which is likely to translate into a 12.8% year-on-year rise in EBITDA.

GCPL’s volume growth is also pegged at 10% year-on-year (YoY), higher than the initial estimate of 8%. The Nuvama analysts further added that the home care segment is likely to post double-digit growth of around 10% YoY, while personal care is expected to grow in the mid-single digits, led by a recovery in soaps.

“Standalone EBITDA margins are seen returning to normalised levels of 24–26%. On the international front, Indonesia is expected to decline about 3% YoY due to continued competitive pricing pressure, whereas the GAUM region is likely to deliver a strong performance,” the analysts added.

GCPL share price

At 10:23 AM, shares of GCPL were trading at ₹1,243.20 apiece on the National Stock Exchange, falling 0.86%.

In a month, shares of the firm have rallied over 10%, while for six months’ time, they have fallen 2%. On a year-on-year basis, GCPL shares have gained 8%.

The company has a market capitalisation of ₹1.27 lakh crore.

Shares of GCPL had touched their one-year high of ₹1,309 apiece on September 4, 2025, while their 52-week low of ₹979.5 was hit on March 4, 2025.